Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

EfficientNet improves accuracy in diagnosing hair loss stages.

This study found no significant relationship between Demodex infestation and androgenetic alopecia in male patients aged 20 to 40.

This study found that hair implantation using a biocompatible polyamide fiber resulted in very satisfactory improvements with a low rate of adverse events among 196 patients.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

This study suggests that greater sensitivity to androgens, as indicated by higher than grade 2 androgenic alopecia, may reduce the risk of schizophrenia by 8.62 times.

This study found that men with androgenic alopecia had significantly lower hair zinc levels compared to controls, but no significant difference in blood zinc levels was observed.

In this study, a combination of GFM-lotion with autologous PRP treatment improved efficacy in treating androgenic alopecia compared to PRP alone, as shown by significant improvements in clinical assessments over 3 months.

This article reviews various diagnostic tools for hair disorders, describing methods ranging from invasive to noninvasive, but reports no new research findings or clinical results.

This study found that the parietal/occipital hair density ratio decreases significantly only when baldness is visibly present, making it no better than the Hamilton/Norwood scale for assessing baldness severity.

This review identified various outcome measure instruments for assessing androgenetic alopecia but found inconsistent application across clinical trials, underscoring the need for standardized assessment methods.

This study found that patients with androgenetic alopecia had significantly higher COVID-19 severity compared to matched controls, suggesting a potential link between androgen pathways and disease severity. The authors suggest further research to validate this hypothesis and explore antiandrogen treatments for managing COVID-19 severity.

This study found that sub-dermal platelet-rich plasma injections were effective for treating androgenic alopecia among both male and female participants.

This study found that platelet-rich plasma injections significantly increased hair count and improved hair loss in patients with androgenic alopecia, with high patient satisfaction and no notable adverse effects.

This study suggests that a high frequency of androgenetic alopecia is associated with increased severity of COVID-19 in hospitalized patients.

This study found that men with early-onset male pattern alopecia did not significantly differ from healthy individuals in cardiovascular and metabolic measures, but hsCRP and galectin-3 were linked to cardiovascular risk factors in those with the condition.

This study compares datasets to analyze the prevalence of androgenetic alopecia in patients admitted with severe COVID-19 in three Madrid hospitals, focusing on age, gender, and alopecia severity.

This study reports that a majority of patients hospitalized with severe COVID-19 in three Madrid hospitals exhibited androgenetic alopecia, termed the "Gabrin Sign".

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

This study noted that among hospitalized COVID-19 patients, androgenetic alopecia was prevalent, and severe cases were associated with adverse outcomes such as respiratory failure, highlighting a possible link with androgen sensitivity.

This study found that androgenetic alopecia is significantly associated with an increased risk of Metabolic Syndrome, particularly in early-onset male cases and females exhibiting severe AGA.

This article proposes enhancing the Norwood-Hamilton scale for assessing hair loss patterns but reports no new clinical results.

This study found that a high proportion of androgenetic alopecia patients were young individuals with mild types, potentially due to psychological stress in social situations.

This study suggests that traditional classification systems for pattern hair loss, while useful in the past, have limitations in accuracy and reproducibility, and highlights the potential of integrating digital imaging and AI to create more precise and biologically informed classification frameworks.

This study found a significant relationship between the severity of androgenetic alopecia in men and a negative impact on their quality of life.

In this study, researchers found that severe androgenic alopecia in hospitalized men was associated with a higher likelihood of testing positive for COVID-19.

This study found no significant association between the degree of male-pattern baldness and serum 25-hydroxyvitamin D levels in healthy middle-aged and older men.

This study found that men with X-linked recessive ichthyosis did not show mutual exclusivity with androgenetic alopecia, as some exhibited advanced hair loss.

This study observed that the genes WNT7A, CASP7, and TNF were overexpressed in early stages of androgenetic alopecia, suggesting involvement of the WNT pathway, apoptosis, and inflammation in the disorder's development.

This letter discusses how severe baldness in men is associated with higher risk of severe COVID-19, and highlights research suggesting antiandrogen medications may improve outcomes.